Publication | Closed Access

Recurrent Amplification at 7q21.2 Targets CDK6 Gene in Primary Myxofibrosarcomas and Identifies CDK6 Overexpression as an Independent Adverse Prognosticator

Hematological MalignancyRecurrent AmplificationIdentifies Cdk6 OverexpressionMedicineMalignant Blood DisorderImmunologyTargets Cdk6 GenePathologyCancer GeneticsMolecular DiagnosticsCancer ResearchTumor BiologyMyeloid Neoplasia